Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D I Marks

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Blood|February 1, 1996
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosisD I Marks, B W Kurz, M P Link, et al.
Leukemia|February 1, 1995
Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrowF van Rhee, D I Marks, F Lin, et al.
Bone Marrow Transplantation|November 1, 1992
Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemiaD I Marks, B Dousset, A Robson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
British Journal of Haematology|March 1, 1996
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndromeD I Marks, E C Vonderheid, B W Kurz, et al.
Clinical Pharmacology and Therapeutics|May 7, 2010
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosisC M Rice, E A Mallam, A L Whone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemiaD I Marks, J M Bird, K Vettenranta, et al.
Bone Marrow Transplantation|August 26, 1998
Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveriesE Clarke, M N Potter, G Hale, et al.
Bone Marrow Transplantation|June 26, 2007
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR studyS Feyler, H M Prince, R Pearce, et al.
British Journal of Haematology|July 1, 1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcomeD I Marks, T P Hughes, R Szydlo, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Blood|February 1, 1996
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosisD I Marks, B W Kurz, M P Link, et al.
Leukemia|February 1, 1995
Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrowF van Rhee, D I Marks, F Lin, et al.
Bone Marrow Transplantation|November 1, 1992
Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemiaD I Marks, B Dousset, A Robson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
British Journal of Haematology|March 1, 1996
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndromeD I Marks, E C Vonderheid, B W Kurz, et al.
Clinical Pharmacology and Therapeutics|May 7, 2010
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosisC M Rice, E A Mallam, A L Whone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemiaD I Marks, J M Bird, K Vettenranta, et al.
Bone Marrow Transplantation|August 26, 1998
Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveriesE Clarke, M N Potter, G Hale, et al.
Bone Marrow Transplantation|June 26, 2007
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR studyS Feyler, H M Prince, R Pearce, et al.
British Journal of Haematology|July 1, 1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcomeD I Marks, T P Hughes, R Szydlo, et al.
Pageof 10